Superhydrophobic
Surface Modification of Polymer Microneedles
Enables Fabrication of Multimodal Surface-Enhanced Raman Spectroscopy
and Mass Spectrometry Substrates for Synthetic Drug Detection in Blood
Plasma
posted on 2023-09-28, 19:37authored byM. Vitoria Simas, Philomena O. Olaniyan, Sumon Hati, Gregory A. Davis, Gavin Anspach, John V. Goodpaster, Nicholas E. Manicke, Rajesh Sardar
Microneedles are widely used substrates for various chemical
and
biological sensing applications utilizing surface-enhanced Raman spectroscopy
(SERS), which is indeed a highly sensitive and specific analytical
approach. This article reports the fabrication of a nanoparticle (NP)-decorated
microneedle substrate that is both a SERS substrate and a substrate-supported
electrospray ionization (ssESI) mass spectrometry (MS) sample ionization
platform. Polymeric ligand-functionalized gold nanorods (Au NRs) are
adsorbed onto superhydrophobic surface-modified polydimethylsiloxane
(PDMS) microneedles through the control of various interfacial interactions.
We show that the chain length of the polymer ligands dictates the
NR adsorption process. Importantly, assembling Au NRs onto the micrometer-diameter
needle tips allows the formation of highly concentrated electromagnetic
hot spots, which provide the SERS enhancement factor as high as 1.0
× 106. The micrometer-sized area of the microneedle
top and high electromagnetic field enhancement of our system can be
loosely compared with tip-enhanced Raman spectroscopy, where the apex
of a plasmonic NP-functionalized sharp probe produces high-intensity
plasmonic hot spots. Utilizing our NR-decorated microneedle substrates,
the synthetic drugs fentanyl and alprazolam are analyzed with a subpicomolar
limit of detection. Further analysis of drug-molecule interactions
on the NR surface utilizing the Langmuir adsorption model suggests
that the higher polarizability of fentanyl allows for a stronger interaction
with hydrophilic polymer layers on the NR surface. We further demonstrate
the translational aspect of the microneedle substrate for both SERS-
and ssESI-MS-based detection of these two potent drugs in 10 drug-of-abuse
(DOA) patient plasma samples with minimal preanalysis sample preparation
steps. Chemometric analysis for the SERS-based detection shows a very
good classification between fentanyl, alprazolam, or a mixture thereof
in our selected 10 samples. Most importantly, ssESI-MS analysis also
successfully identifies fentanyl or alprazolam in these same 10 DOA
plasma samples. We believe that our multimodal detection approach
presented herein is a highly versatile detection technology that can
be applicable to the detection of any analyte type without performing
any complicated sample preparation.